1 / 8

Charcot-Marie-Tooth Disease Market To Surpass US$ 3459.1 Million By 2028

Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neurological disorders. More than 40 genes have been identified in CMT, and each gene is associated with one or more diseases.

SANJAYCMI
Télécharger la présentation

Charcot-Marie-Tooth Disease Market To Surpass US$ 3459.1 Million By 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CHARCOT MARIE TOOTH DISEASE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Charcot-Marie-Tooth Disease Market- Overview Charcot-Marie-Tooth (CMT) disease is the most common inherited neurologic disorder that cause nerve damage. CMT is not life threatening and most people with the condition have the same life expectancy as a person without the condition. CMT is a progressive condition, which means the symptoms gradually get worse over time. The degree of disability varies according to the CMT subtype. There's no cure for CMT, but braces, physical/occupational therapy, and other orthopedic devices, and even orthopedic surgery can help cope with the symptoms of the disease. Charcot-marie- tooth disease generally progresses slowly, and it doesn't affect expected life span. CMT cannot be stopped or reversed, but it can reach a point where the progression steadies itself. Available therapies help reduce the symptoms of CMT. The global charcot-marie-tooth disease market is estimated to be valued at US$ 3459.1 Million in 2027 and is expected to exhibit a CAGR of 23.4% over the forecast period (2018-2026), as highlighted in a new report published by Coherent Market Insights. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/charcot- marie-tooth-disease-market-4698 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION • Competitive Landscape: • Major players operating in the global charcot-marie-tooth disease market are Neurogene Inc., Helixmith Co., Ltd., Bristol-Myers-Squibb Company, MedDay Pharmaceuticals, Acceleron Pharma, Genzyme Corp, Affectis Pharmaceuticals AG, Addex Therapeutics Ltd., Inflectis Bio Science Health Company, Pharnext SA, and Lead Discovery Center GmbH, among others. • Key Market Drivers: • Increasing prevalence of charcot-marie-tooth disease across the globe is expected to augment the growth of the charcot-marie-tooth disease market during the forecast period. For instance, according to MedlinePlus, an online information service produced by the U.S. National Library of Medicine, CMT is the most common genetic disease; 1 in every 3,300 people in the world is affected by charcot-marie-tooth disease. • Moreover, increasing development of novel therapeutics for the treatment of CMT is expected to boost growth of the charcot-marie-tooth disease market. For instance, in October 2020, the CMT Research Foundation launched a new research program to develop a precision medicine approach for charcot-marie-tooth (CMT) disease. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/4698 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION • Key Takeaways: • The charcot-marie-tooth disease market is expected to exhibit a CAGR of 23.4 % during the forecast period due to increased focus towards targeted therapies and increasing research and development activities. For instance, in October 09, 2018, Vitaccess and Pharnext SA launched an international study on charcot-marie-tooth disease. The objective of the study is to better understand the impact of the disease on patients’ daily lives: the burden of CMT, its natural history and treatment, and medical, social, and pharmacoeconomic effects. • Among regions, North America is expected to witness robust growth in the charcot- marie-tooth disease market owing to the high prevalence of CMT, introduction of novel therapies for the treatment of CMT, and continuous research and development (R&D) in this region. For instance, according to MedlinePlus, CMT is the most common inherited disorder that affects an estimated 150,000 people in the United States. • Moreover, in February 2019, Pharnext announced that the Food and Drug Administration (FDA) granted Fast Track designation for the development of PXT3003 for the treatment of patients with Charcot-Marie-Tooth disease Type 1A (CMT1A). Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4698 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related